Company intelligence / Profile preview
Dermaliq Therapeutics, Inc.
Wilmington, Delaware, USAdermaliq.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dermaliq Therapeutics has reported statistically significant positive topline results from a randomized, blinded vehicle and comparator-controlled clinical Phase 1b/2a trial of its lead candidate DLQ01 for androgenetic alopecia. Over 80% of subjects responded positively with increased hair growth. The company’s pipeline leverages its proprietary hyliQ® topical drug delivery technology to address follicular diseases and other dermatological conditions with improved efficacy and safety profiles compared to existing therapies.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small molecules (e.g., prostaglandin F2α analogs)Topical formulationsCalcineurin inhibitorsAntibiotics (topical)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Investors include Novaliq GmbH, dievini Hopp BioTech holding GmbH & Co. KG, Beijing Whale Technology Corporation Ltd., and 3E Bioventures Capital.Academic collaboration noted with Prof. Ralf Paus at University of Miami Miller School of Medicine regarding translational hair research.
Beyond the preview
Go deeper on Dermaliq Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermaliq Therapeutics, Inc..